Increased right ventricular cardiomyocyte stiffness in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012
Right ventricular stiffness impairs right atrial function in pulmonary arterial hypertension Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020
Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension and their relationship with right ventricular structure and function Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013
Prognostic relevance of right atrial function in pulmonary arterial hypertension Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension Year: 2017
Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018
How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1700764; 10.1183/13993003.00764-2017 Year: 2017
The role of the right ventricle in pulmonary arterial hypertension Source: Eur Respir Rev 2011; 20: 243-253 Year: 2011
Right ventricular size and contractile reserve significantly correlate in patients with pulmonary hypertension Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise Year: 2018
The influence of right ventricular diastolic functions and pulmonary hypertension on exercise limitation and their relationship with serum NT-proBNP levels in COPD Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension Source: Eur Respir J 2008; 31: 1160-1166 Year: 2008
Left ventricular diastolic function in patients with high altitude-induced pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 98s Year: 2002
Macitentan in pulmonary hypertension due to left ventricular dysfunction Source: Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017 Year: 2018
Relation between hemodynamics and right ventricular hypertrophy may affect survival and severity of the disease in patients with primary pulmonary hypertension (PPH) Source: Eur Respir J 2002; 20: Suppl. 38, 26s Year: 2002
Right ventricular and pulmonary vascular interaction in pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases Year: 2008
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension Source: Eur Respir J, 57 (4) 1901192; 10.1183/13993003.01192-2019 Year: 2021
Reduced right ventricular transverse wall motion is indicative of right ventricular dysfunction in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009
Improved right ventricular function after substantial afterload reduction in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment Year: 2012
Native myocardial T1 correlates with right ventricular remodelling in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016
Pulmonary hypertension, right and left ventricular dysfunction in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006